Epidemiological evidence has also proposed targeting of retinoids and the retinoic acid pathways for chemoprevention of colorectal cancer and the increased expression of CYP26A1 and CYP26B1 in colorectal cancer would indicate that targeting these enzymes may be a useful approach [70]–[72]. The gene discussed is CYP26A1; the disease is colorectal cancer.